Elm Street Ventures backs Yale Spin-out Artizan BioSciences
Elm Street Ventures announced that it has invested in Artizan Biosciences, Inc. as part of a $5 million Series A financing round. The financing was led by Hatteras Venture Partners.
Recent Posts
- Stradefy Biosciences Appoints Jeffrey M. Goldberg as Executive Chair
- P2 Science appoints Oihana Elizalde, PhD as Chief Executive Officer
- CellFE secures $22 million in Series A financing
- Yale Announces Major Upgrade to Engineering Campus
- Desmos Sells Curriculum Business to Amplify Education and Spins Out Desmos Studio PBC